Building confidence at the edge through embedded trust anchors

Tern plc

As digital infrastructure expands across sectors such as healthcare, energy, and manufacturing, the cost of weak or default identities is no longer theoretical. Every unverified connection introduces potential disruption, regulatory risk, and in the most critical environments, threats to safety itself.

Device Authority has placed this foundational challenge at the centre of its Zero Trust strategy. Through its KeyScaler® platform, the company has redefined how identity and policy can be embedded at the edge, directly within the manufacturing and onboarding stages of connected devices. By automating the creation of strong, unique identities tied to secure hardware or generated dynamically where hardware roots of trust do not exist, the system removes the manual processes that often lead to configuration errors and scalability issues. This enables manufacturers and operators to secure fleets of devices from the instant they connect, without human intervention or bottlenecks.

When partnered with Olympus, KeyScaler allows trust anchors to feed directly into enterprise identity and access management systems, ensuring that every device remains under continuous policy governance. Context, behaviour, and health signals can trigger automated responses, from restricted access to complete revocation, ensuring that any anomaly is addressed instantly and proportionately.

Importantly, Device Authority’s approach also acknowledges industrial reality. Many enterprises must work with extensive brownfield environments where legacy assets lack the modern security hardware of new devices. For these cases, KeyScaler’s Dynamic Device Key Generation and Trust on First Use models create strong, software-based identities that can later be reinforced through re-enrolment or attestation.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets better pharmaceutical launch results through message analysis

Talking Medicines' Message Resonance Score measures doctors' understanding of pharmaceutical messaging to help companies improve launch strategies.

Device Authority addresses security risks as AI takes control of physical machines

Device Authority's KeyScaler platform supports secure AI-driven automation by helping organisations authenticate connected machines, protect device identities and control access to physical equipment.

Talking Medicines examines factors influencing prescribing decisions

Talking Medicines explains how healthcare professional conversations, clinical considerations and treatment perceptions can provide pharmaceutical companies with deeper insight into prescribing intent beyond traditional campaign metrics.

What HCPs say could reveal prescribing intent

Talking Medicines is using AI to analyse HCP conversations and identify the clinical and practical factors that may influence prescribing intent.

AI control of machines raises new security questions

AI is gaining the ability to control physical equipment, but establishing that machines are genuine, authorised and secure will be an important part of making this technology safe to deploy.

CAR-T therapy brings new approach to multiple myeloma treatment

CAR-T therapy is being used in multiple myeloma and is being studied earlier in the treatment pathway, with research focused on improving durability, safety and access.

Search